Medpace Holdings Inc (MEDP) Stock Analysis

Medpace Holdings Inc (MEDP) is a publicly traded company in the HEALTHCARE sector. It trades at $445.59, carries a market capitalization of $12.89B, a price-to-earnings ratio of 28.43. This page summarizes the public market data, fundamentals, and frequently asked questions for MEDP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $445.59
• Market Cap: $12.89B
• P/E Ratio: 28.43
• EPS: $15.88
• 52-Week High: $628.92
• 52-Week Low: $293.20

Market Sentiment

Medpace Holdings Inc currently has a Bearish sentiment score of -0.40.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a global leader in providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. Headquartered in Cincinnati, Ohio, the firm operates across North America, Europe, and Asia, offering expertise in every phase of the clinical development process. Medpace stands out for its commitment to high-quality execution and regulatory compliance, enabling clients to effectively advance their products from development through t...

GNG Research Analysis

GNG Research scores Medpace Holdings Inc (MEDP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MEDP.

Frequently Asked Questions

Does MEDP pay dividends?

Medpace Holdings Inc (MEDP) does not currently pay a regular dividend.

What is MEDP's P/E ratio?

Medpace Holdings Inc has a price-to-earnings (P/E) ratio of 28.43.

What is MEDP's market cap?

Medpace Holdings Inc (MEDP) has a market capitalization of $12.89B with a current stock price of $445.59.